坎地沙坦联合胺碘酮对心力衰竭合并心房颤动患者心功能及血清炎症因子的影响(4)
[15] Friedrichs K,Klinke A,Baldus S. Inflammatory pathways underlying atrial fibrillation[J]. Trends Mol Med,2011, 17(10):556-563.
[16] Umebayashi R,Uchida HA,Okuyama Y,et al. The clinical efficacy of angiotensin Ⅱ type1 receptor blockers on inflammatory markers in patients with hypertension:A multicenter randomized-controlled trial[J]. MUSCAT-3 Study Biomarkers,2019,24(3):255-261.
[17] 候雨,张杨,关群,等. 坎地沙坦联合貝那普利治疗原发性高血压的临床疗效[J]. 当代医学,2020,26(17):12-14.
[18] 韩美如. 坎地沙坦与贝那普利治疗慢性充血性心力衰竭的效果及对神经内分泌激素活性的影响[J]. 中国医学创新,2020,17(8):10-14.
[19] 顾学林,黄爽,刘维华,等. 培哚普利和坎地沙坦的时间治疗学对非杓型高血压的影响[J]. 中外医学研究,2019, 17(19):4-6.
[20] Delcayre C,Swynghedauw B. Molecular mechanisms of myocardial remodeling. The role of aldosterone[J]. J Mol Cell Cardiol,2002,34(12):1577-1584.
[21] Tomaschitz A,Pilz S,Ritz E,et al. Plasma aldosterone levels are associated with increased cardiovascular mortality:The ludwigshafen risk and cardiovascular health(LURIC) study[J]. Eur Heart J,2010,31(10):1237-1247.
(收稿日期:2020-07-17), http://www.100md.com(刘育成)
[16] Umebayashi R,Uchida HA,Okuyama Y,et al. The clinical efficacy of angiotensin Ⅱ type1 receptor blockers on inflammatory markers in patients with hypertension:A multicenter randomized-controlled trial[J]. MUSCAT-3 Study Biomarkers,2019,24(3):255-261.
[17] 候雨,张杨,关群,等. 坎地沙坦联合貝那普利治疗原发性高血压的临床疗效[J]. 当代医学,2020,26(17):12-14.
[18] 韩美如. 坎地沙坦与贝那普利治疗慢性充血性心力衰竭的效果及对神经内分泌激素活性的影响[J]. 中国医学创新,2020,17(8):10-14.
[19] 顾学林,黄爽,刘维华,等. 培哚普利和坎地沙坦的时间治疗学对非杓型高血压的影响[J]. 中外医学研究,2019, 17(19):4-6.
[20] Delcayre C,Swynghedauw B. Molecular mechanisms of myocardial remodeling. The role of aldosterone[J]. J Mol Cell Cardiol,2002,34(12):1577-1584.
[21] Tomaschitz A,Pilz S,Ritz E,et al. Plasma aldosterone levels are associated with increased cardiovascular mortality:The ludwigshafen risk and cardiovascular health(LURIC) study[J]. Eur Heart J,2010,31(10):1237-1247.
(收稿日期:2020-07-17), http://www.100md.com(刘育成)